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Obstructive sleep apnea
in women: Prevalence, risk
factors and relation
to menopausal status
Apneia obstrutiva do sono nas mulheres:
Prevalência, factores de risco e relac¸ão com a
menopausa
Dear Editor,
Obstructive sleep apnea (OSA) is two to ﬁve times more
prevalent in men than women but this gender-related dif-
ference is attenuated after menopause.1--4 Many of the
hypotheses that explain the gender differences in OSA are
based on the hormonal dissimilarities between men and
women and the protective effect of circulating progesterone
in women. So, one would expect that postmenopausal
women with OSA would beneﬁt from hormonal replacement
therapy (HRT) but studies done so far are based on small
series and still inconclusive.2,5
The aim of this study was to describe the prevalence,
severity and risk factors for OSA in women, particularly
menopause and HRT. We performed a retrospective analysis
of women submitted to overnight polysomnography (PSG)
at the Sleep Laboratory of Coimbra’s University Hospital
between 2004 and 2013. Clinical reports were reviewed and
pertinent clinical data retrieved, including Body Mass Index
(BMI), sleep-related complaints, comorbidities and previous
medication. Menopausal status, according to the WHO clas-
siﬁcation, and other gynecological details were attained by
a preset telephone questionnaire.
Table 1 Comparison of descriptive variables among women subm
and December 2013.
Variable All women OSA women
OSA Non-OSA p-Value Premenopausal P
n = 223 n = 180 n = 64 n
Age, years 57.4 ± 10.1 49.2 ± 11.2 0.000 48.4 ± 10.5 6
AHI, events/h 23.9 ± 25.5 1.1 ± 1.3 0.000 21.5 ± 24.9 2
SpO2 < 90%,
min
27.3 ± 54.7 3.2 ± 17.0 0.000 18.7 ± 37.0 3
ODI, events/h 17.0 ± 17.1 2.7 ± 8.7 0.000 13.3 ± 14.0 1
Lowest SpO2,
%
80.2 ± 10.2 91.0 ± 5.4 0.000 81.6 ± 10.9 7
BMI, kg/m2 32.9 ± 8.2 28.6 ± 5.6 0.000 33.1 ± 7.8 3
ESS, score 9.4 ± 6.5 8.8 ± 6.7 ns 9.7 ± 6.2
OSA-related
symptoms, n
4.6 ± 2.2 4.6 ± 2.1 ns 4.4 ± 2.2
Cardiovascular
risk factors, n
0.9 ± 0.2 0.8 ± 0.4 0.000 0.9 ± 0.3
OSA: obstructive sleep apnea; HRT: hormonal replacement therapy; w/
peripheral saturation; ODI: oxygen desaturation index; BMI: body mass
are displayed as mean± standard deviation.
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From a total of 745 consecutive female patients, 403
et the inclusion criteria of this study, 55.3% of which
ad OSA. Univariate analysis showed that OSA women
ere signiﬁcantly older (p = 0.000), had more frequent
omplaints of nycturia and dry mouth (p < 0.025), more
ardiovascular risk factors (p = 0.000) and a higher risk
or overweight/obesity, diabetes, arterial hypertension and
yslipidemia (p < 0.032). Women without OSA had more day-
ime sleepiness (p = 0.012), which could be explained by
he higher risk for depression and/or anxiety (p = 0.001).
fter menopause, women with OSA were older (p = 0.000),
ad more frequent complaints of nycturia (p = 0.000) and
two-to-fourfold higher risk for diabetes, dyslipidaemia
nd arterial hypertension (p < 0.037) but had no signiﬁcant
olysomnographic differences compared to premenopausal
omen. AHI was signiﬁcantly higher for postmenopausal
omen without HRT compared to those with HRT, but
here where no relevant symptomatic differences between
he two groups (Table 1). Multiple regression showed that
ge and BMI independently predicted OSA while depression
nd/or anxiety was negatively correlated with the risk of
SA. No signiﬁcant association between OSA and menopause
r HRT could be found in multivariate analysis adjusted
or age.
In conclusion, age and BMI were the two main inde-
endent risk factors for OSA in women. Menopause was
ssociated to OSA as part of the aging process itself, which
as been corroborated by previous studies that showed aitted to overnight polysomnography between January 2004
OSA postmenopausal women
ostmenopausal p-Value w/HRT w/o HRT P-Value
= 159 n = 13 n = 146
1.0 ± 7.3 0.000 54.9 ± 5.6 61.6 ± 7.2 0.002
4.9 ± 25.8 ns 15.4 ± 13.5 25.7 ± 26.5 0.026
0.7 ± 60.1 ns 5.6 ± 9.5 33.0 ± 62.2 ns
8.5 ± 18.0 0.038 12.5 ± 13.2 19.1 ± 18.3 ns
9.6 ± 9.9 ns 79.7 ± 8.1 79.6 ± 10.0 ns
2.8 ± 8.3 ns 34.5 ± 15.3 32.6 ± 7.5 ns
9.3 ± 6.6 ns 10.3 ± 7.1 9.2 ± 6.6 ns
4.7 ± 2.2 ns 4.3 ± 2.0 4.8 ± 2.2 ns
1.0 ± 0.2 ns 2.1 ± 1.0 2.0 ± 1.1 ns
: with; w/o: without; AHI: apnea--hypopnea index; SpO2: oxygen
index; ESS: Epworth sleepiness scale; ns: not signiﬁcant. Values
igher prevalence of OSA after menopause.2,3 HRT showed
o beneﬁts for decreasing the risk for OSA. Clinical pre-
entation was similar between women with or without
SA.
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Diagnosis of pulmonary
sequestration using imaging
methods
Diagnóstico de sequestro pulmonar usando
métodos de imagiologia
Dear Editor:
Pulmonary sequestration (PS) is a rare congenital malfor-
mation. Several reports describe preoperative diagnostic
difﬁculties with this pathology.1--3 The authors report a case
of intralobar sequestration (IS) and intend to draw attention
to the importance of imaging modalities, including Com-
puted Tomography (CT) with contrast for the diagnosis, in
order to reduce the number of patients sent for surgery
without an accurate diagnosis.
IS corresponds to 75--90% of all sequestrations consisting
of non-functioning lung tissue that falls within the normal
lung parenchyma without its own visceral pleura; it is usually
unrelated to the tracheobronchial tree. It is irrigated by an
abnormal systemic artery derived mainly from the aorta.
About 20% of cases are irrigated by more than one artery.1--3
IS presents frequently in adolescents and young adults,
but rarely in adults over 40 years, with recurrent infection
and hemoptysis; 15% of patients are asymptomatic.1,2
The diagnosis is suggested by the identiﬁcation of the
abnormal blood vasculature in imaging studies. The average
rate of reported preoperative misdiagnosis in the literature
is high. Angiography used to be considered the method of
Surgical resection is the treatment of choice.1,2
Case report: Female patient, Caucasian, 64 years old,
house cleaner, no smoking or alcohol habits. Referred for
pulmonology evaluation because she had asthenia and ady-
namia with one-year evolution, weight loss (13 kg in six
months), a CT showing ﬁbrosis areas, traction bronchiectasis
and an encysted and loculated left pleural effusion.
In relation to antecedents, the key was anaemia of
unknown cause and an episode of respiratory infection which
dragged on (one year ago). She did not report any hemoptysis
episodes.
A thoracic CT with contrast was performed and showed
a vascular image in the internal basal segment of the left
lower lobe, 47mm× 47mm, with at least two arteries orig-
inating from the lower thoracic aorta; this was suggestive
of PS. There were also ﬁbrosis areas and bronchiectasis
(Fig. 1).
A left lower lobectomy was performed and the anomalous
arteries were joined up. An anatomopathological examina-
tion showed a cavitary formation of 5 cm, with apparent
communication with the bronchial tree and pulmonary
condensation of the surrounding parenchyma. Microscop-
ically, this was a cystic lesion lined with respiratory
epithelium; adjacent to this, there were many dilated and
mucous retention airspaces, tortuous blood vessels and wall
thickening, which are consistent with IS.
A diagnostic hypothesis suggested from the ﬁrst CT
(without contrast) was encysted pleural effusion. The per-
formance of CT with contrast was central to the correct
diagnosis of preoperative PS.
In this case, the highlights are the unusual age
choice for preoperative diagnosis, has been replaced by non-
invasive methods. Conventional CT does not consistently
show anomalous arterial supply. Thus, CT with contrast has
emerged as the imaging test of choice.1--5
o
u
a
tf onset of clinical presentation, nonspeciﬁc and
ncharacteristic symptomatology, PS irrigated by two
rteries and communication with the tracheobronchial
ree.
